Technical Analysis for ANR - Anatara Lifesciences Ltd
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Inside Day | Range Contraction | -4.88% | |
| Fell Below 20 DMA | Bearish | -9.30% | |
| New Downtrend | Bearish | -9.30% | |
| Wide Bands | Range Expansion | -9.30% | |
| Gapped Down | Weakness | -9.30% | |
| Wide Bands | Range Expansion | -15.22% | |
| Gapped Up | Strength | -15.22% |
| Alert | Time |
|---|---|
| Fell Below Previous Day's Low | 2 days ago |
| Down 3% | 2 days ago |
| Down 2% | 2 days ago |
| Down 1% | 2 days ago |
| Down 3% | 5 days ago |
Get this analysis on your stocks daily!
Anatara Lifesciences Ltd Description
Anatara Lifesciences Ltd is an Australia-based company focused on developing oral solutions for gastrointestinal diseases in production animals and humans and the development and commercialization of Detach, a non-antibiotic therapy that prevents and treats diarrhea (scour) in piglets. Detach is a modified release formulation of BromelainRx, a natural extract from pineapple stems. Detach helps in address the overuse of antibiotics in animals. It is formulated with various ingredients to allow oral administration and delivery to the small intestine. The Company is focused on developing Detach for pigs in Australia and then expanding the program to Europe and the United States. The Company is also developing a similar version of Detach to prevent diarrhea in humans. The Company is seeking to collaborate with pharmaceutical/biotechnology companies for clinical development and commercialization of a similar version of Detach for human application in travelers and military personnel.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Gas Medicine Pharmaceutical Biotechnology Disease Travel Diseases Medical Specialties Therapy Pharmaceuticals Policy Animals Military Antibiotic Humans Inr Antibiotics Biotechnology Companies Sanitation Veterinary Medicine Digestive System
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.076 |
| 52 Week Low | 0.021 |
| Average Volume | 261,303 |
| 200-Day Moving Average | 0.032 |
| 50-Day Moving Average | 0.036 |
| 20-Day Moving Average | 0.044 |
| 10-Day Moving Average | 0.046 |
| Average True Range | 0.003 |
| RSI (14) | 37.89 |
| ADX | 23.41 |
| +DI | 26.355 |
| -DI | 34.483 |
| Chandelier Exit (Long, 3 ATRs) | 0.042 |
| Chandelier Exit (Short, 3 ATRs) | 0.042 |
| Upper Bollinger Bands | 0.050 |
| Lower Bollinger Band | 0.037 |
| Percent B (%b) | 0.13 |
| BandWidth | 29.291 |
| MACD Line | 0.002 |
| MACD Signal Line | 0.003 |
| MACD Histogram | -0.0012 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.039 | ||||
| Resistance 3 (R3) | 0.039 | 0.039 | 0.039 | ||
| Resistance 2 (R2) | 0.039 | 0.039 | 0.039 | 0.039 | |
| Resistance 1 (R1) | 0.039 | 0.039 | 0.039 | 0.039 | 0.039 |
| Pivot Point | 0.039 | 0.039 | 0.039 | 0.039 | 0.039 |
| Support 1 (S1) | 0.039 | 0.039 | 0.039 | 0.039 | 0.039 |
| Support 2 (S2) | 0.039 | 0.039 | 0.039 | 0.039 | |
| Support 3 (S3) | 0.039 | 0.039 | 0.039 | ||
| Support 4 (S4) | 0.039 |
